Osteoarthritis | Rheumatoid arthritis | Reactive arthritis | |
---|---|---|---|
sLeX (CD15s) | |||
PB | 109.0 (22.6) | 431.0 (60.3)2-150 | 402.9 (61.1)2-150 |
SF | 138.5 (13.8) | 169.1 (24.3) | 186.4 (43.0) |
LFA-1 (CD11a) | |||
PB | 210.9 (7.5) | 250.5 (21.7)† | 340.2 (12.3)2-150 |
SF | 189.7 (9.4) | 213.6 (21.3) | 194.5 (7.8) |
VLA-4 (CD49d) | |||
PB | 83.8 (5.2) | 76.2 (9.6) | 90.7 (5.0) |
SF | 122.6 (5.3) | 93.2 (14.1)† | 127.0 (7.3) |
ICAM-1 (CD54) | |||
PB | 51.8 (6.8) | 47.6 (9.4)† | 99.2 (24.0) |
SF | 99.0 (20.7) | 120.0 (24.1)† | 217.1 (31.3)2-150 |
CD44 | |||
PB | 111.1 (13.2) | 152.9 (39.3) | 234.6 (29.3)2-150 |
SF | 270.9 (19.6) | 382.7 (123.0) | 470.1 (26.3)2-150 |
HLA-DR | |||
PB | 343.8 (80.1) | 568.0 (130.5) | 649.1 (85.3)2-150 |
SF | 1079.5 (187.0) | 2003.8 (389.8)2-150 | 2233.0 (136.5)2-150 |
↵2-150 Indicates statistically significant difference compared with OA patients. †Indicates statistically significant difference between RA and REA (p<0.05).